IV Dosing, Wt-Based

Weight‑based IV dosing means adjusting the intravenous drug dose proportionally to the patient’s body weight to optimize safety and efficacy.

g/kgmg/kgmcg/kg
g/mLmg/mLmcg/mL
kglbs

Indikationen

Use weight‑based IV dosing when drug distribution and clearance correlate with body size (eg, anticoagulants, thrombolytics, many pediatric emergency drugs). Clinical utility: improves target drug exposure, reduces underdosing or toxicity, and standardizes dosing across weights. Evidence: weight‑based enoxaparin achieves superior anti‑Xa levels versus fixed dosing in critically ill patients 1 [Level I evidence]; full weight‑based chemotherapy dosing maintains efficacy in obese adults without increased toxicity 2 [Level II evidence].

Hinweise & Vorsichtsmaßnahmen

Use actual weight when known, but confirm accuracy; in emergencies, length‑based tools often underestimate weight by 10–20% 1 [Level I evidence]. Avoid automatic dose increases in obesity—data show no proven safety for adjusted‑weight strategies and risk of inaccurate dosing 2 [Level II evidence]. Monitor renal function closely for renally cleared medications. For narrow‑therapeutic‑index drugs, titrate to clinical effect or drug levels.